ZyVersa Therapeutics Stock Target Price and Analyst Consensus
| ZVSA Stock | 1.07 0.04 3.60% |
The current analyst and expert consensus on ZyVersa Therapeutics is Strong Buy, with only one strong buy opinion. The current projected ZyVersa Therapeutics target price consensus is 2.50 with 1 analyst opinions. Check out Macroaxis Advice on ZyVersa Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade ZyVersa Stock refer to our How to Trade ZyVersa Stock guide.The most common way ZyVersa Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview ZyVersa Therapeutics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on ZyVersa Therapeutics. We encourage you to use your own analysis of ZyVersa Therapeutics to validate this buy or sell advice. ZyVersa Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected ZyVersa Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 8.3415.
Lowest Forecast 2.28 | Highest Forecast 2.78 | Target Price 2.5 |
ZyVersa |
It's important to approach ZyVersa Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize ZyVersa Therapeutics price targets
ZyVersa Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using ZyVersa Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at ZyVersa Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if ZyVersa Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional ZyVersa Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of ZyVersa Therapeutics is a key component of ZyVersa Therapeutics valuation and have some predictive power on the future returns of a ZyVersa Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ZyVersa Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested over 90 shares | |
 | Hedge Favorites Invested over 40 shares | |
 | Investor Favorites Invested few shares | |
 | Manufacturing Invested over 30 shares | |
 | Impulse Invested over 100 shares | |
 | Momentum Invested over 50 shares | |
 | Business Services Invested few shares | |
 | Blockchain Invested few shares | |
 | FinTech Invested over 40 shares |
Check out Macroaxis Advice on ZyVersa Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade ZyVersa Stock refer to our How to Trade ZyVersa Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Please note, the presentation of ZyVersa Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ZyVersa Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ZyVersa Therapeutics' management manipulating its earnings.